Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$1.93 +0.13 (+7.22%)
As of: Nov 11, 2026 · 1:02 PM EST

Zentalis Pharmaceuticals (ZNTL) Goodwill impairment charges (2024)

Updated

Zentalis Pharmaceuticals (ZNTL) posted Goodwill impairment charges of $3.7 million for Q4 2024.

Analysis

Zentalis Pharmaceuticals (ZNTL) Goodwill impairment charges (2024) Analysis & Trends

For FY2024, Zentalis Pharmaceuticals' Goodwill impairment charges came in at $3.74 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Zentalis Pharmaceuticals 176.87 Mn -684.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 3.70 Mn
API Access

Zentalis Pharmaceuticals Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=ZNTL&period=max&api_key=YOUR_API_KEY